These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32386596)

  • 21. Discovery of E3 Ligase Ligands for Target Protein Degradation.
    Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ligase ligand chemistries: from building blocks to protein degraders.
    Sosič I; Bricelj A; Steinebach C
    Chem Soc Rev; 2022 May; 51(9):3487-3534. PubMed ID: 35393989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins.
    Yang Y; Wu Z; Chen P; Zheng P; Zhang H; Zhou J
    Future Med Chem; 2020 Sep; 12(18):1669-1683. PubMed ID: 32893690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice.
    Perland E; Hellsten SV; Schweizer N; Arapi V; Rezayee F; Bushra M; Fredriksson R
    PLoS One; 2017; 12(10):e0186325. PubMed ID: 29049335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ABCs of membrane transporters in health and disease (SLC series): introduction.
    Hediger MA; Clémençon B; Burrier RE; Bruford EA
    Mol Aspects Med; 2013; 34(2-3):95-107. PubMed ID: 23506860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
    Fredriksson R; Nordström KJ; Stephansson O; Hägglund MG; Schiöth HB
    FEBS Lett; 2008 Nov; 582(27):3811-6. PubMed ID: 18948099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
    Ishida T; Ciulli A
    SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras.
    Zhang X; Luukkonen LM; Eissler CL; Crowley VM; Yamashita Y; Schafroth MA; Kikuchi S; Weinstein DS; Symons KT; Nordin BE; Rodriguez JL; Wucherpfennig TG; Bauer LG; Dix MM; Stamos D; Kinsella TM; Simon GM; Baltgalvis KA; Cravatt BF
    J Am Chem Soc; 2021 Apr; 143(13):5141-5149. PubMed ID: 33783207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging mechanisms of targeted protein degradation by molecular glues.
    Frere GA; de Araujo ED; Gunning PT
    Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic SLC family genes promote cell proliferation, migration, and invasion in hepatocellular carcinoma.
    Fang X; Liu Y; Xiao W; Zhao N; Zhu C; Yu D; Zhao Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):1065-1075. PubMed ID: 34128989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study.
    Burslem GM; Smith BE; Lai AC; Jaime-Figueroa S; McQuaid DC; Bondeson DP; Toure M; Dong H; Qian Y; Wang J; Crew AP; Hines J; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):67-77.e3. PubMed ID: 29129716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural biology of solute carrier (SLC) membrane transport proteins.
    Bai X; Moraes TF; Reithmeier RAF
    Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake.
    Perland E; Hellsten SV; Lekholm E; Eriksson MM; Arapi V; Fredriksson R
    J Mol Neurosci; 2017 Feb; 61(2):199-214. PubMed ID: 27981419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL.
    Lai AC; Toure M; Hellerschmied D; Salami J; Jaime-Figueroa S; Ko E; Hines J; Crews CM
    Angew Chem Int Ed Engl; 2016 Jan; 55(2):807-10. PubMed ID: 26593377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications.
    Li Q; Zhou L; Qin S; Huang Z; Li B; Liu R; Yang M; Nice EC; Zhu H; Huang C
    Eur J Med Chem; 2023 Sep; 257():115447. PubMed ID: 37229829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody targeting of E3 ubiquitin ligases for receptor degradation.
    Marei H; Tsai WK; Kee YS; Ruiz K; He J; Cox C; Sun T; Penikalapati S; Dwivedi P; Choi M; Kan D; Saenz-Lopez P; Dorighi K; Zhang P; Kschonsak YT; Kljavin N; Amin D; Kim I; Mancini AG; Nguyen T; Wang C; Janezic E; Doan A; Mai E; Xi H; Gu C; Heinlein M; Biehs B; Wu J; Lehoux I; Harris S; Comps-Agrar L; Seshasayee D; de Sauvage FJ; Grimmer M; Li J; Agard NJ; de Sousa E Melo F
    Nature; 2022 Oct; 610(7930):182-189. PubMed ID: 36131013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.
    Wang K; Dai X; Yu A; Feng C; Liu K; Huang L
    J Exp Clin Cancer Res; 2022 Sep; 41(1):289. PubMed ID: 36171633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules.
    Hickey CM; Digianantonio KM; Zimmermann K; Harbin A; Quinn C; Patel A; Gareiss P; Chapman A; Tiberi B; Dobrodziej J; Corradi J; Cacace AM; Langley DR; Békés M
    Nat Struct Mol Biol; 2024 Feb; 31(2):311-322. PubMed ID: 38177675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras.
    Madan J; Ahuja VK; Dua K; Samajdar S; Ramchandra M; Giri S
    BioDrugs; 2022 Sep; 36(5):609-623. PubMed ID: 36098871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
    Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
    Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.